EMEA-001793-PIP01-15-M03 - paediatric investigation plan
Bivalent anti-human myostatin adnectin recombinant human IgG1-Fc fusion protein (RO7239361)
PIPHuman
Roche Registration GmbH
Tel. +41 616879411
E-mail: global.paediatrics@roche.com
P/0043/2019: EMA decision of 29 January 2019 on the acceptance of a modification of an agreed paediatric investigation plan for bivalent anti-human myostatin adnectin recombinant human IgG1-Fc fusion protein (RO7239361) (EMEA-001793-PIP01-15- M03 )